Société Kiniksa Pharmaceuticals International, plc
Actions
KNSA
GB00BRXB0C07
Recherche biotechnologique et médicale
Temps réel estimé
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
19,18 USD | +0,39% |
|
+2,81% | +9,44% |
Métier
Nombre d'employés: 297
Ventes par activité
USD en Millions | 2022 | Poids | 2023 | Poids | Delta |
---|---|---|---|---|---|
Therapeutic Medicines
100,0
%
| 220 | 100,0 % | 270 | 100,0 % | +22,74% |
Ventes par région
USD en Millions | 2022 | Poids | 2023 | Poids | Delta |
---|---|---|---|---|---|
Bermuda
100,0
%
| 220 | 100,0 % | 270 | 100,0 % | +22,74% |
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Eben Tessari
FOU | Founder | 42 | 01/07/15 |
Sanj Patel
CEO | Chief Executive Officer | 54 | 01/07/15 |
Mark Ragosa
DFI | Director of Finance/CFO | 50 | 01/05/18 |
Chad Morin
CMP | Compliance Officer | - | 01/10/20 |
John Paolini
CTO | Chief Tech/Sci/R&D Officer | 59 | 01/08/16 |
Rachel Frank
IRC | Investor Relations Contact | - | - |
General Counsel | - | 01/08/20 | |
Ross Moat
PRN | Corporate Officer/Principal | 43 | 01/01/19 |
Martina Struck
LAW | General Counsel | - | 01/01/18 |
Melissa Manno
HRO | Human Resources Officer | - | 01/01/17 |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Felix Baker
BRD | Director/Board Member | 55 | 01/10/15 |
Barry Quart
BRD | Director/Board Member | 67 | 01/10/15 |
Thomas Malley
BRD | Director/Board Member | 55 | 01/12/16 |
Richard Levy
BRD | Director/Board Member | 66 | 04/03/19 |
Kim Popovits
BRD | Director/Board Member | 65 | 01/02/18 |
G. Cole
BRD | Director/Board Member | 68 | 27/07/20 |
Stephen Biggar
BRD | Director/Board Member | 53 | 01/10/15 |
Sanj Patel
CEO | Chief Executive Officer | 54 | 01/07/15 |
Tracey McCain
BRD | Director/Board Member | 56 | 01/02/18 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 16 057 618 | 0 | 0 | 54,38 % |
Action B | 1 | 12 781 964 | 0 | 0 | |
Action C | 1 | 1 795 158 | 0 | 0 | |
Action D | 1 | 40 305 405 | 38 579 583 ( 95,72 %) | 0 |
Coordonnées société
![Adresse Kiniksa Pharmaceuticals International, plc(KNSA)](https://cdn.zonebourse.com/static/address/43459706.png)
Secteur
![Consensus](/images/consensus_flch.gif)
Révisions de BNA
Varia. 1 janv. | Capi. | |
---|---|---|
+9,44% | 1,36 Md | |
+16,12% | 121 Md | |
+17,68% | 110 Md | |
+17,47% | 25,98 Md | |
-24,80% | 19,27 Md | |
-18,77% | 15,99 Md | |
-18,51% | 15,66 Md | |
-48,32% | 14,5 Md | |
+56,67% | 14,47 Md | |
+4,10% | 13,91 Md |
- Bourse
- Actions
- Action KNSA
- Société Kiniksa Pharmaceuticals International, plc